Technical Analysis for BIOC - Biocept, Inc.

Grade Last Price % Change Price Change
grade F 1.12 3.70% 0.04
BIOC closed up 3.7 percent on Tuesday, March 19, 2019, on 52 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Mar 26

*** please verify all earnings dates ***
13 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical BIOC trend table...

Date Alert Name Type % Chg
Mar 19 Crossed Above 20 DMA Bullish 0.00%
Mar 19 Calm After Storm Range Contraction 0.00%
Mar 19 Narrow Range Bar Range Contraction 0.00%
Mar 19 NR7 Range Contraction 0.00%
Mar 19 Stochastic Reached Oversold Weakness 0.00%
Mar 19 Inside Day Range Contraction 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 19 Oversold Stochastic Weakness 0.00%
Mar 18 Fell Below 20 DMA Bearish 3.70%
Mar 18 Wide Bands Range Expansion 3.70%

Older signals for BIOC ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
Biocept, Inc., a cancer diagnostics company, is engaged in the development and commercialization of proprietary circulating tumor cell (CTC) and circulating tumor DNA tests. The company's tests provide information to oncologists that enable them to select the appropriate treatment for their patients based on detailed data on the characteristics of tumors. Its tests include OncoCEE-BR, a breast cancer CTC test that allows physician to characterize the tumor to help define treatment options. The company sells its products through its sales force and partners that focus on selling directly to community oncologists in hospitals, cancer centers, and offices in the United States. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.
Medicine Cancer Medical Specialties Clinical Medicine Oncology Tumor Tumors Anatomical Pathology
Is BIOC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Mar 18 Biocept Awarded Patent in Japan for the Capture of Rare Cells Including CTCs from Any Biological Sample of Interest with A Microchannel Device
Mar 18 Biocept, Potential Near-Term Catalysts for Biocept
Mar 15 Midday Gainers / Losers
Mar 15 Achieve Life Sciences and Karyopharm Therapeutics among healthcare gainers; Biocept and BioScrip among losers
Mar 15 Biocept down 23% on pricing $8.2M registered direct offering
Mar 15 KIRK and FRSX among premarket losers
Mar 15 Biocept Announces Pricing of $8.2 Million Registered Direct Offering
Mar 14 CLDR, TLRD, MDB and WAGE among midday movers
Mar 13 Biocept expands pathology partnership platform; shares up 7% premarket
Mar 13 Biocept Expands its Pathology Partnership Offering for Liquid Biopsy with the Addition of Several Key Services
See more BIOC news...
Indicators
Indicator Value
52 Week High 12.15
52 Week Low 0.66
Average Volume 3,099,682
200-Day Moving Average 2.9495
50-Day Moving Average 1.4112
20-Day Moving Average 1.0945
10-Day Moving Average 1.161
Average True Range 0.1876
ADX 21.55
+DI 31.5447
-DI 15.3134
Chandelier Exit (Long, 3 ATRs ) 1.1472
Chandelier Exit (Short, 3 ATRs ) 1.5428
Upper Bollinger Band 1.3548
Lower Bollinger Band 0.8342
Percent B (%b) 0.55
BandWidth 47.565098
MACD Line -0.0367
MACD Signal Line -0.0658
MACD Histogram 0.0291
Fundamentals Value
Market Cap 33.89 Million
Num Shares 30.3 Million
EPS -1.06
Price-to-Earnings (P/E) Ratio -1.06
Price-to-Sales 5.54
Price-to-Book 3.79
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.24
Resistance 3 (R3) 1.23 1.19 1.22
Resistance 2 (R2) 1.19 1.16 1.19 1.21
Resistance 1 (R1) 1.15 1.14 1.17 1.16 1.21
Pivot Point 1.11 1.11 1.12 1.11 1.11
Support 1 (S1) 1.07 1.08 1.09 1.08 1.03
Support 2 (S2) 1.03 1.06 1.03 1.03
Support 3 (S3) 0.99 1.03 1.02
Support 4 (S4) 1.00